Pharmaceutical Glycerin Based Products Market By Drug Type (Dermatological, Opthalmic, Cough Remidies, Glycerine Rectal, Angina): Global Opportunity Analysis and Industry Forecast, 2020-2030

Pharmaceutical Glycerin Based Products Market

Pharmaceutical glycerin is an organic compound known as glycerol and glycerin and is majorly used as an excipient in the pharmaceutical industry. Glycerin exhibits various benefits in medical and pharmaceutical preparations, such as improving smoothness, lubrication, and humectant. It is most commonly utilized in the formulation of suppositories, cough syrups, elixirs, and expectorants.

As an individual prescription product, glycerin has been used as a hyperosmotic, osmotic diuretic, and ophthalmic agent. It may be used as an eye drop in the treatment of glaucoma to reduce intraocular pressure, as a solution or suppository for short-term treatment of constipation, to evacuate the bowel prior to colonoscopy, and in some ocular surgeries. It may be given intravenously to reduce pressure inside the brain and used externally on the skin as a moisturizer. Glycerin has many other uses in the agricultural, food, and pharmaceutical industries.

An increase in the adoption of pharmaceutical glycerin products is due to an increase in the use of glycerin in various products. As glycerin is used as excipients in pharmaceutical products, the demand for these products globally is expected to drive the pharmaceuticals glycerin-based products market.

Furthermore, an increase in the use of glycerin as a substitute for alcohol in herbal and botanical tincture preparation is anticipated to drive the market. In addition, the increase in the adoption of glycerin in the pharmaceutical industry owing to its low cost and various medical benefits, such as moisturizers in skin burns & minor skin irritations are the key factors that drive the growth of the market in the upcoming year..

The pharmaceutical glycerin-based product market is segmented on the basis of drug type and region. On the basis of drug type, the market is divided into dermatological, ophthalmic, cough remedies glycerin rectal, and angina. On the basis of region, the pharmaceutical glycerin-based product market is divided across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in the global pharmaceutical glycerin-based product market include Johnson & Johnson, Abbott, AbbVie Inc. Bausch Health Companies Inc., Takeda Pharmaceutical Companies, The Dow Chemical Company, Dupont, Emery Oleochemicals, Croda International Plc, and Lonza

Scope of Pharmaceutical Glycerin Based Products Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Dermatological

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.3 Opthalmic

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

4.4 Cough Remidies

4.4.1 Key market trends, growth factors and opportunities

4.4.2 Market size and forecast, by region

4.4.3 Market analysis by country

4.5 Glycerine Rectal

4.5.1 Key market trends, growth factors and opportunities

4.5.2 Market size and forecast, by region

4.5.3 Market analysis by country

4.6 Angina

4.6.1 Key market trends, growth factors and opportunities

4.6.2 Market size and forecast, by region

4.6.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 North America

5.2.1 Key trends and opportunities

5.2.2 North America Market size and forecast, by Drug Type

5.2.3 North America Market size and forecast, by country

5.2.3.1 U.S.

5.2.3.1.1 Market size and forecast, by Drug Type

5.2.3.2 Canada

5.2.3.2.1 Market size and forecast, by Drug Type

5.2.3.3 Mexico

5.2.3.3.1 Market size and forecast, by Drug Type

5.3 Europe

5.3.1 Key trends and opportunities

5.3.2 Europe Market size and forecast, by Drug Type

5.3.3 Europe Market size and forecast, by country

5.3.3.1 Germany

5.3.3.1.1 Market size and forecast, by Drug Type

5.3.3.2 France

5.3.3.2.1 Market size and forecast, by Drug Type

5.3.3.3 U.K.

5.3.3.3.1 Market size and forecast, by Drug Type

5.3.3.4 Italy

5.3.3.4.1 Market size and forecast, by Drug Type

5.3.3.5 Spain

5.3.3.5.1 Market size and forecast, by Drug Type

5.3.3.6 Rest of Europe

5.3.3.6.1 Market size and forecast, by Drug Type

5.4 Asia-Pacific

5.4.1 Key trends and opportunities

5.4.2 Asia-Pacific Market size and forecast, by Drug Type

5.4.3 Asia-Pacific Market size and forecast, by country

5.4.3.1 Japan

5.4.3.1.1 Market size and forecast, by Drug Type

5.4.3.2 China

5.4.3.2.1 Market size and forecast, by Drug Type

5.4.3.3 Australia

5.4.3.3.1 Market size and forecast, by Drug Type

5.4.3.4 India

5.4.3.4.1 Market size and forecast, by Drug Type

5.4.3.5 South Korea

5.4.3.5.1 Market size and forecast, by Drug Type

5.4.3.6 Rest Of Asia Pacific

5.4.3.6.1 Market size and forecast, by Drug Type

5.5 LAMEA

5.5.1 Key trends and opportunities

5.5.2 LAMEA Market size and forecast, by Drug Type

5.5.3 LAMEA Market size and forecast, by country

5.5.3.1 Brazil

5.5.3.1.1 Market size and forecast, by Drug Type

5.5.3.2 South Africa,

5.5.3.2.1 Market size and forecast, by Drug Type

5.5.3.3 Saudi Arabia

5.5.3.3.1 Market size and forecast, by Drug Type

5.5.3.4 Rest of LAMEA

5.5.3.4.1 Market size and forecast, by Drug Type

6.1. Introduction

6.2. Top winning strategies

6.3. Product Mapping of Top 10 Player

6.4. Competitive Dashboard

6.5. Competitive Heatmap

6.6. Key developments

7.1 Johnson and Johnson

7.1.1 Company overview

7.1.2 Company snapshot

7.1.3 Operating business segments

7.1.4 Product portfolio

7.1.5 Business performance

7.1.6 Key strategic moves and developments

7.2 Abbott Laboratories

7.2.1 Company overview

7.2.2 Company snapshot

7.2.3 Operating business segments

7.2.4 Product portfolio

7.2.5 Business performance

7.2.6 Key strategic moves and developments

7.3 AbbVie Inc

7.3.1 Company overview

7.3.2 Company snapshot

7.3.3 Operating business segments

7.3.4 Product portfolio

7.3.5 Business performance

7.3.6 Key strategic moves and developments

7.4 Bausch Health Companies Inc.

7.4.1 Company overview

7.4.2 Company snapshot

7.4.3 Operating business segments

7.4.4 Product portfolio

7.4.5 Business performance

7.4.6 Key strategic moves and developments

7.5 Takeda Pharmaceutical Company

7.5.1 Company overview

7.5.2 Company snapshot

7.5.3 Operating business segments

7.5.4 Product portfolio

7.5.5 Business performance

7.5.6 Key strategic moves and developments

7.6 Takeda Pharmaceutical Company Ltd

7.6.1 Company overview

7.6.2 Company snapshot

7.6.3 Operating business segments

7.6.4 Product portfolio

7.6.5 Business performance

7.6.6 Key strategic moves and developments

7.7 The Dow Chemical Company

7.7.1 Company overview

7.7.2 Company snapshot

7.7.3 Operating business segments

7.7.4 Product portfolio

7.7.5 Business performance

7.7.6 Key strategic moves and developments

7.8 dupoint

7.8.1 Company overview

7.8.2 Company snapshot

7.8.3 Operating business segments

7.8.4 Product portfolio

7.8.5 Business performance

7.8.6 Key strategic moves and developments

7.9 Emery Oleochemicals

7.9.1 Company overview

7.9.2 Company snapshot

7.9.3 Operating business segments

7.9.4 Product portfolio

7.9.5 Business performance

7.9.6 Key strategic moves and developments

7.10 Croda International plc

7.10.1 Company overview

7.10.2 Company snapshot

7.10.3 Operating business segments

7.10.4 Product portfolio

7.10.5 Business performance

7.10.6 Key strategic moves and developments

7.11 Capsugel

7.11.1 Company overview

7.11.2 Company snapshot

7.11.3 Operating business segments

7.11.4 Product portfolio

7.11.5 Business performance

7.11.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY DRUG TYPE, 2020-2030,($MILLION)

TABLE 2. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET REVENUE, FOR DERMATOLOGICAL, BY REGION , 2020-2030,($MILLION)

TABLE 3. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET DERMATOLOGICAL BY COUNTRY, 2020-2030,($MILLION)

TABLE 4. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET REVENUE, FOR OPTHALMIC, BY REGION , 2020-2030,($MILLION)

TABLE 5. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET OPTHALMIC BY COUNTRY, 2020-2030,($MILLION)

TABLE 6. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET REVENUE, FOR COUGH REMIDIES, BY REGION , 2020-2030,($MILLION)

TABLE 7. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET COUGH REMIDIES BY COUNTRY, 2020-2030,($MILLION)

TABLE 8. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET REVENUE, FOR GLYCERINE RECTAL, BY REGION , 2020-2030,($MILLION)

TABLE 9. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET GLYCERINE RECTAL BY COUNTRY, 2020-2030,($MILLION)

TABLE 10. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET REVENUE, FOR ANGINA, BY REGION , 2020-2030,($MILLION)

TABLE 11. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET ANGINA BY COUNTRY, 2020-2030,($MILLION)

TABLE 12. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY REGION, 2020-2030,($MILLION)

TABLE 13. NORTH AMERICA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY DRUG TYPE, 2020-2030,($MILLION)

TABLE 14. NORTH AMERICA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 15. U.S. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)

TABLE 16. CANADA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)

TABLE 17. MEXICO PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)

TABLE 18. EUROPE PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY DRUG TYPE, 2020-2030,($MILLION)

TABLE 19. EUROPE PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 20. GERMANY PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)

TABLE 21. FRANCE PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)

TABLE 22. U.K. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)

TABLE 23. ITALY PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)

TABLE 24. SPAIN PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)

TABLE 25. REST OF EUROPE PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)

TABLE 26. ASIA-PACIFIC PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY DRUG TYPE, 2020-2030,($MILLION)

TABLE 27. ASIA-PACIFIC PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 28. JAPAN PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)

TABLE 29. CHINA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)

TABLE 30. AUSTRALIA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)

TABLE 31. INDIA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)

TABLE 32. SOUTH KOREA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)

TABLE 33. REST OF ASIA PACIFIC PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)

TABLE 34. LAMEA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY DRUG TYPE, 2020-2030,($MILLION)

TABLE 35. LAMEA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 36. BRAZIL PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)

TABLE 37. SOUTH AFRICA, PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)

TABLE 38. SAUDI ARABIA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)

TABLE 39. REST OF LAMEA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)

TABLE 40.JOHNSON AND JOHNSON: COMPANY SNAPSHOT

TABLE 41.JOHNSON AND JOHNSON: OPERATING SEGMENTS

TABLE 42.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO

TABLE 43.JOHNSON AND JOHNSON: NET SALES,

TABLE 44.JOHNSON AND JOHNSON: KEY STRATERGIES

TABLE 45.ABBOTT LABORATORIES: COMPANY SNAPSHOT

TABLE 46.ABBOTT LABORATORIES: OPERATING SEGMENTS

TABLE 47.ABBOTT LABORATORIES: PRODUCT PORTFOLIO

TABLE 48.ABBOTT LABORATORIES: NET SALES,

TABLE 49.ABBOTT LABORATORIES: KEY STRATERGIES

TABLE 50.ABBVIE INC: COMPANY SNAPSHOT

TABLE 51.ABBVIE INC: OPERATING SEGMENTS

TABLE 52.ABBVIE INC: PRODUCT PORTFOLIO

TABLE 53.ABBVIE INC: NET SALES,

TABLE 54.ABBVIE INC: KEY STRATERGIES

TABLE 55.BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT

TABLE 56.BAUSCH HEALTH COMPANIES INC.: OPERATING SEGMENTS

TABLE 57.BAUSCH HEALTH COMPANIES INC.: PRODUCT PORTFOLIO

TABLE 58.BAUSCH HEALTH COMPANIES INC.: NET SALES,

TABLE 59.BAUSCH HEALTH COMPANIES INC.: KEY STRATERGIES

TABLE 60.TAKEDA PHARMACEUTICAL COMPANY: COMPANY SNAPSHOT

TABLE 61.TAKEDA PHARMACEUTICAL COMPANY: OPERATING SEGMENTS

TABLE 62.TAKEDA PHARMACEUTICAL COMPANY: PRODUCT PORTFOLIO

TABLE 63.TAKEDA PHARMACEUTICAL COMPANY: NET SALES,

TABLE 64.TAKEDA PHARMACEUTICAL COMPANY: KEY STRATERGIES

TABLE 65.TAKEDA PHARMACEUTICAL COMPANY LTD: COMPANY SNAPSHOT

TABLE 66.TAKEDA PHARMACEUTICAL COMPANY LTD: OPERATING SEGMENTS

TABLE 67.TAKEDA PHARMACEUTICAL COMPANY LTD: PRODUCT PORTFOLIO

TABLE 68.TAKEDA PHARMACEUTICAL COMPANY LTD: NET SALES,

TABLE 69.TAKEDA PHARMACEUTICAL COMPANY LTD: KEY STRATERGIES

TABLE 70.THE DOW CHEMICAL COMPANY: COMPANY SNAPSHOT

TABLE 71.THE DOW CHEMICAL COMPANY: OPERATING SEGMENTS

TABLE 72.THE DOW CHEMICAL COMPANY: PRODUCT PORTFOLIO

TABLE 73.THE DOW CHEMICAL COMPANY: NET SALES,

TABLE 74.THE DOW CHEMICAL COMPANY: KEY STRATERGIES

TABLE 75.DUPOINT: COMPANY SNAPSHOT

TABLE 76.DUPOINT: OPERATING SEGMENTS

TABLE 77.DUPOINT: PRODUCT PORTFOLIO

TABLE 78.DUPOINT: NET SALES,

TABLE 79.DUPOINT: KEY STRATERGIES

TABLE 80.EMERY OLEOCHEMICALS: COMPANY SNAPSHOT

TABLE 81.EMERY OLEOCHEMICALS: OPERATING SEGMENTS

TABLE 82.EMERY OLEOCHEMICALS: PRODUCT PORTFOLIO

TABLE 83.EMERY OLEOCHEMICALS: NET SALES,

TABLE 84.EMERY OLEOCHEMICALS: KEY STRATERGIES

TABLE 85.CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT

TABLE 86.CRODA INTERNATIONAL PLC: OPERATING SEGMENTS

TABLE 87.CRODA INTERNATIONAL PLC: PRODUCT PORTFOLIO

TABLE 88.CRODA INTERNATIONAL PLC: NET SALES,

TABLE 89.CRODA INTERNATIONAL PLC: KEY STRATERGIES

TABLE 90.CAPSUGEL: COMPANY SNAPSHOT

TABLE 91.CAPSUGEL: OPERATING SEGMENTS

TABLE 92.CAPSUGEL: PRODUCT PORTFOLIO

TABLE 93.CAPSUGEL: NET SALES,

TABLE 94.CAPSUGEL: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET SEGMENTATION

FIGURE 2.PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030

FIGURE 3.PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 11.PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,BY DRUG TYPE,2020(%)

FIGURE 12.COMPARATIVE SHARE ANALYSIS OF DERMATOLOGICAL PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF OPTHALMIC PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030(%)

FIGURE 14.COMPARATIVE SHARE ANALYSIS OF COUGH REMIDIES PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030(%)

FIGURE 15.COMPARATIVE SHARE ANALYSIS OF GLYCERINE RECTAL PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030(%)

FIGURE 16.COMPARATIVE SHARE ANALYSIS OF ANGINA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030(%)

FIGURE 17.PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY REGION,2020

FIGURE 18.U.S. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)

FIGURE 19.CANADA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)

FIGURE 20.MEXICO PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)

FIGURE 21.GERMANY PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)

FIGURE 22.FRANCE PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)

FIGURE 23.U.K. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)

FIGURE 24.ITALY PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)

FIGURE 25.SPAIN PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)

FIGURE 26.REST OF EUROPE PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)

FIGURE 27.JAPAN PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)

FIGURE 28.CHINA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)

FIGURE 29.AUSTRALIA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)

FIGURE 30.INDIA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)

FIGURE 31.SOUTH KOREA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)

FIGURE 32.REST OF ASIA PACIFIC PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)

FIGURE 33.BRAZIL PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)

FIGURE 34.SOUTH AFRICA, PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)

FIGURE 35.SAUDI ARABIA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)

FIGURE 36.REST OF LAMEA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)

FIGURE 37. TOP WINNING STRATEGIES, BY YEAR

FIGURE 38. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 39. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 40.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 41.COMPETITIVE DASHBOARD

FIGURE 42.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 43.JOHNSON AND JOHNSON.: NET SALES ,($MILLION)

FIGURE 44.ABBOTT LABORATORIES.: NET SALES ,($MILLION)

FIGURE 45.ABBVIE INC.: NET SALES ,($MILLION)

FIGURE 46.BAUSCH HEALTH COMPANIES INC..: NET SALES ,($MILLION)

FIGURE 47.TAKEDA PHARMACEUTICAL COMPANY.: NET SALES ,($MILLION)

FIGURE 48.TAKEDA PHARMACEUTICAL COMPANY LTD.: NET SALES ,($MILLION)

FIGURE 49.THE DOW CHEMICAL COMPANY.: NET SALES ,($MILLION)

FIGURE 50.DUPOINT.: NET SALES ,($MILLION)

FIGURE 51.EMERY OLEOCHEMICALS.: NET SALES ,($MILLION)

FIGURE 52.CRODA INTERNATIONAL PLC.: NET SALES ,($MILLION)

FIGURE 53.CAPSUGEL.: NET SALES ,($MILLION